Intellia Therapeutics (NTLA) News
NASDAQ: NTLAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
13.07+0.47 (+3.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NTLA news summary
We found 1 recent headline mentioning Intellia Therapeutics (NTLA): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, NTLA is up 3.73% at $13.07. The most recent story, "Pre-Market Most Active for Apr 29, 2026 : KALV, SOFI, NOK, INTC, NTLA, HOOD, TQQQ, BBAI, NIO, SMR, SAN, BE", was published by Nasdaq on Apr 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology